Position in LLY
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$13,882,203
+$3,435,456 QoQ
Shares Held
11,574
+1.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.07%
of 13F equity value
Holder Rank
#1,073
of 4,604 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Stonebridge Capital Advisors LLC holds $79,452,749 across 7 Drug Manufacturers - General names. LLY ranks #4 (17.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
86,589 | $21,991,008 | |
| 2 | MRK |
Merck & Co., Inc.
|
148,656 | $19,102,296 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
112,875 | $14,260,627 | |
| 4 | LLY |
ELI LILLY & Co
This page
|
11,574 | $13,882,203 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
162,082 | $9,339,164 | |
| 6 | PFE |
Pfizer Inc
|
20,095 | $483,887 | |
| 7 | ABBV |
AbbVie Inc.
|
1,564 | $393,564 |
All Filings in LLY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,882,203 | 11,574 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $10,446,747 | 11,358 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $11,773,120 | 10,955 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $8,025,997 | 10,519 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,961,297 | 2,516 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $1,909,503 | 2,312 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,460,624 | 1,892 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,346,855 | 2,649 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $2,381,149 | 2,630 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $2,106,715 | 2,708 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $1,647,331 | 2,826 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $935,143 | 1,741 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $854,950 | 1,823 | Shares | Sole | 2023-08-23 | |
| 2023-03-31 | $693,021 | 2,018 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $719,241 | 1,966 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $637,646 | 1,972 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $650,729 | 2,007 | Shares | Sole | 2022-08-12 | |
| 2021-12-31 | $523,989 | 1,897 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $432,294 | 1,871 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $347,263 | 1,513 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $282,658 | 1,513 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $289,222 | 1,713 | Shares | Sole | 2021-03-05 | |
| 2020-09-30 | $232,243 | 1,569 | Shares | Sole | 2020-11-18 | |
| 2020-06-30 | $253,165 | 1,542 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $255,522 | 1,842 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||